Mucosal Healing With Infliximab Biosimilar in Ulcerative ColitisMucosal Healing With Infliximab Biosimilar in Ulcerative Colitis
About two-thirds of patients with ulcerative colitis (UC) had mucosal healing by the end of induction treatment with the infliximab biosimilar CT-P13, according results of the first prospective study to evaluate this. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 2, 2016 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Colectomy dominates TNF-α inhibitors for ulcerative colitis
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2016 Category: Drugs & Pharmacology Source Type: news

Appendectomy and Colectomy Risk in Ulcerative ColitisAppendectomy and Colectomy Risk in Ulcerative Colitis
Appendectomy does not decrease, and may increase, the risk of colectomy in patients with ulcerative colitis (UC), according to a retrospective study and meta-analysis. Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - April 30, 2016 Category: Surgery Tags: Gastroenterology News Source Type: news

Minimally invasive colitis screening using infrared technology could offer fast, simple test
A minimally invasive screening for ulcerative colitis, a debilitating gastrointestinal tract disorder, using emerging infrared technology could be a rapid and cost-effective method for detecting disease that eliminates the need for biopsies and intrusive testing of the human body, according to researchers. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 26, 2016 Category: Science Source Type: news

Minimally invasive colitis screening using infrared technology could offer fast, simple test
(Georgia State University) A minimally invasive screening for ulcerative colitis, a debilitating gastrointestinal tract disorder, using emerging infrared technology could be a rapid and cost-effective method for detecting disease that eliminates the need for biopsies and intrusive testing of the human body, according to researchers at Georgia State University. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 26, 2016 Category: Global & Universal Source Type: news

Colitis-Associated Cancers Differ From Sporadic Colorectal CancersColitis-Associated Cancers Differ From Sporadic Colorectal Cancers
Genomic data show differences between colitis-associated cancers and sporadic colorectal cancers and between those associated with Crohn's disease and ulcerative colitis (UC), researchers report. Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - April 25, 2016 Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news

Anti-TNF Drug and Antidrug Antibody Level Monitoring in IBDAnti-TNF Drug and Antidrug Antibody Level Monitoring in IBD
Can monitoring of anti-TNF drug levels help patients achieve stable remission of Crohn disease or ulcerative colitis? Frontline Gastroenterology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 21, 2016 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Hacking Gut Bacteria Could Be The Future Of Medicine
The human gut microbiome -- which includes the community of trillions of bacteria living within our intestines -- has been called one of the next big frontiers in medicine.  In recent years, a growing body of research has shown that the bacteria in our gut exert a powerful influence on our immune and endocrine systems, brain health, mood and cognitive function, and other key biological processes. We know that the balance of good and bad bacteria in the gut can keep us healthy -- or can contribute to disease. Now, the next step for this exciting medical frontier is learning how to leverage the power of the microbi...
Source: Healthy Living - The Huffington Post - April 11, 2016 Category: Consumer Health News Source Type: news

Hacking Gut Bacteria Could Be The Future Of Medicine
The human gut microbiome -- which includes the community of trillions of bacteria living within our intestines -- has been called one of the next big frontiers in medicine.  In recent years, a growing body of research has shown that the bacteria in our gut exert a powerful influence on our immune and endocrine systems, brain health, mood and cognitive function, and other key biological processes. We know that the balance of good and bad bacteria in the gut can keep us healthy -- or can contribute to disease. Now, the next step for this exciting medical frontier is learning how to leverage the power of the microbi...
Source: Science - The Huffington Post - April 11, 2016 Category: Science Source Type: news

Women With These Diseases May Be Needlessly Limiting Their Fertility Options
By Lisa Rapaport (Reuters Health) - Many women with a bowel disorder that can affect fertility choose not to attempt pregnancy even though treatment may make it possible for them to conceive, a recent study suggests. Researchers studied more than 1,300 women with inflammatory bowel disease (IBD), which involves chronic or recurring inflammation of the gastrointestinal tract. Ulcerative colitis and Crohn’s disease are the most common forms of IBD. People with Crohn’s have inflammation throughout the entire digestive tract, while in ulcerative colitis, only the large intestine is inflamed. Almost one in six women...
Source: Healthy Living - The Huffington Post - April 8, 2016 Category: Consumer Health News Source Type: news

FDA approves biosimilar to J&J's Remicade for multiple diseases
(Reuters) - The U.S. Food and Drug Administration on Tuesday approved Inflectra, a cheaper version of Johnson & Johnson's drug Remicade, to treat Crohn's disease, ulcerative colitis, rheumatoid arthritis, psoriasis and arthritis of the spine. (Source: Reuters: Health)
Source: Reuters: Health - April 5, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

Infliximab not cost effective for ulcerative colitis in Poland
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2016 Category: Drugs & Pharmacology Source Type: news

Shire Wins Patent Trial Against Watson Concerning LIALDA(R)
LIALDA Patent Upheld and Extends through June 8, 2020 LEXINGTON, Massachusetts, March 29, 2016 -- (Healthcare Sales & Marketing Network) -- Shire plc (LSE: SHP, NASDAQ: SHPG) and its subsidiary, Shire Development LLC, announced today that the United St... Biopharmaceuticals, Generics, LitigationShire plc, LIALDA, mesalamine, Watson Pharmaceuticals, ulcerative colitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 29, 2016 Category: Pharmaceuticals Source Type: news

Shire gets favorable ruling against Allergan in Lialda patent case
(Reuters) - A U.S. district court on Monday ruled in favor of Shire Plc, preventing Allergan Plc from selling generic versions of Lialda, the ulcerative colitis drug, in the United States until 2020. (Source: Reuters: Health)
Source: Reuters: Health - March 28, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

Study: Fecal Transplants May Help Colitis
After 8 weeks of fecal transplants, some people with tough-to-treat ulcerative colitis had no rectal bleeding or diarrhea, according to a new study. WebMD has the details. (Source: WebMD Health)
Source: WebMD Health - March 22, 2016 Category: Consumer Health News Source Type: news

Data presented at ECCO congress supports switching from Remicade® to biosimilar infliximab
Ten independent studies validate the growing bank of real-life clinical evidence to support switching patients from the reference infliximab (Remicade®) to biosimilar infliximab (Source: Pharmacy Europe)
Source: Pharmacy Europe - March 22, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Biosimilars Healthcare professionals Practical therapeutics Patient care Research European Crohn ’s and Colitis Organisation ibd immunogenicity infliximab Latest News remicade switching ulcerative colitis Source Type: news

Colitis Improves in Multidonor Fecal Transplant TrialColitis Improves in Multidonor Fecal Transplant Trial
Fecal microbiota transplantation can induce remission in patients with treatment-resistant ulcerative colitis, but there are still some concerns about safety, according to experts. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 21, 2016 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Pfizer reports positive results from Phase III ulcerative colitis trials of tofacitinib
US drugmaker Pfizer has reported positive results from the first two Phase III trials of tofacitinib in adults with moderately to severely active ulcerative colitis (UC). (Source: Drug Development Technology)
Source: Drug Development Technology - March 21, 2016 Category: Pharmaceuticals Source Type: news

Inflammation Predicts Neoplasia in Ulcerative ColitisInflammation Predicts Neoplasia in Ulcerative Colitis
A new strategy to assess the risk for colorectal cancer in patients with ulcerative colitis can be incorporated into clinical practice, researchers report. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 18, 2016 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Pfizer's Xeljanz meets goals in ulcerative colitis trials
(Reuters) - Pfizer Inc said on Friday its Xeljanz rheumatoid arthritis drug succeeded in meeting primary and secondary goals of a pair of late stage clinical trials in ulcerative colitis, results that could help pave the way for an additional approval for the oral medicine. (Source: Reuters: Health)
Source: Reuters: Health - March 18, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

The Practical Management of Acute Severe Ulcerative ColitisThe Practical Management of Acute Severe Ulcerative Colitis
This new article outlines the most current strategies for the management of acute severe ulcerative colitis. Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 9, 2016 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Six Ways to Lower Your Risk for Colon Cancer
By Stacy Simon Colon cancer is one of the more common cancers in the US. About 1 in 20 Americans will develop colon cancer at some point during their lifetime. But there are things you can do to help lower your colon cancer risk. Here are 6 ways to help protect your colon health. Get screened for colon cancer. Screenings are tests that look for cancer before signs and symptoms develop. Colon screenings can often find growths called polyps that can be removed before they turn into cancer. These tests also can find colon cancer earlier, when treatments are more likely to be successful. The American Cancer Society recommend...
Source: American Cancer Society :: News and Features - March 8, 2016 Category: Cancer & Oncology Tags: Colon/Rectum Cancer Source Type: news

Asana Medical, Inc. Names Dr. Christine V. Sapan CEO, Adds University of Miami's Sergio M. Gonzalez to Its Board of Directors
MIAMI LAKES, FL--(Healthcare Sales & Marketing Network) - Asana Medical, Inc., ("Asana," the "Company"), an emerging life science company focused on the development and commercialization of its innovative tissue engineered therapy to t... Biopharmaceuticals, Gastroenterology, PersonnelAsana Medical, tissue engineered therapies, Ulcerative Colitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 2, 2016 Category: Pharmaceuticals Source Type: news

Infliximab May Top Cyclosporine for Steroid-Refractory Ulcerative ColitisInfliximab May Top Cyclosporine for Steroid-Refractory Ulcerative Colitis
Infliximab may be slightly better than cyclosporine for treating patients with steroid-refractory ulcerative colitis (UC), according to results from a systematic review and meta-analysis. Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - March 1, 2016 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Signs and Symptoms of Colon Cancer
By Stacy Simon Many of the symptoms of colon cancer can also be caused by something that isn’t cancer, such as infection, hemorrhoids, irritable bowel syndrome, or inflammatory bowel disease. In most cases, people who have these symptoms do not have cancer. Still, if you have any of these problems, it is a sign that you should go to the doctor so the cause can be found and treated, if needed:A change in bowel habits, such as diarrhea, constipation, or narrowing of the stool, that lasts for more than a few daysA feeling that you need to have a bowel movement that is not relieved by doing soRectal bleedingDark stools, ...
Source: American Cancer Society :: News and Features - February 29, 2016 Category: Cancer & Oncology Tags: Colon/Rectum Cancer Prevention/Early Detection Source Type: news

Inflammatory Bowel Disease and Colorectal Cancer
Inflammatory bowel disease, often characterized by conditions such as ulcerative colitis and Chron's disease, increases the risk of developing colorectal cancer. (Source: About.com Colon Cancer)
Source: About.com Colon Cancer - February 28, 2016 Category: Cancer & Oncology Authors: coloncancer.guide at about.com Tags: health Source Type: news

Vedolizumab Safe for Inflammatory Bowel DiseaseVedolizumab Safe for Inflammatory Bowel Disease
Vedolizumab safely treats ulcerative colitis and Crohn's disease, researchers report in a study that integrates safety data from six clinical trials. Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - February 25, 2016 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Vinegar may help treat bowel condition ulcerative colitis
Chinese scientists have found that both vinegar and its main component, acetic acid, significantly reduced symptoms of ulcerative colitis when given to mice. (Source: the Mail online | Health)
Source: the Mail online | Health - February 15, 2016 Category: Consumer Health News Source Type: news

Medical News Today: Ulcerative colitis may be treatable with vinegar
Giving mice with ulcerative colitis small amounts of vinegar - or its main ingredient acetic acid - significantly reduces symptoms of the inflammatory bowel disease, study shows. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 11, 2016 Category: Consumer Health News Tags: Crohn's / IBD Source Type: news

Vinegar may help treat ulcerative colitis
Stephen FellerWASHINGTON, Feb. 10 (UPI) -- Vinegar suppressed inflammation-inducing proteins linked to ulcerative colitis and improved gut bacteria in the gut, easing the condition in a study with mice. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 10, 2016 Category: Consumer Health News Source Type: news

Vinegar could potentially help treat ulcerative colitis
(American Chemical Society) Vinegar is the perfect ingredient for making tangy sauces and dressings. Now, researchers report in ACS' Journal of Agricultural and Food Chemistry that the popular liquid could also help fight ulcerative colitis, an inflammatory bowel disease that research suggests is related to the gut microbiome. They found that vinegar suppressed inflammation-inducing proteins while improving the gut's bacterial makeup in mice. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 10, 2016 Category: Biology Source Type: news

Surveying the Latest Findings in Inflammatory Bowel Disease Surveying the Latest Findings in Inflammatory Bowel Disease
Dr Stephen Hanauer discusses recent advances in the causation, management, and treatment of ulcerative colitis and Crohn disease. Medscape Gastroenterology (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - February 9, 2016 Category: Gastroenterology Tags: Gastroenterology Commentary Source Type: news

Galapagos bowel drug fails in research trial
BRUSSELS (Reuters) - Belgian biotech group Galapagos said its experimental drug to treat bowel disease ulcerative colitis had failed to prove its efficacy in a medical trial and it would discontinue the program for that disease. (Source: Reuters: Health)
Source: Reuters: Health - January 26, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

No Benefit Seen for Probiotics in Ulcerative Colitis
(MedPage Today) -- Cochrane review showed similar relapse rates for mesalazine and probiotics (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - December 11, 2015 Category: Gastroenterology Source Type: news

Infliximab-Associated Hepatic Failure in Ulcerative ColitisInfliximab-Associated Hepatic Failure in Ulcerative Colitis
While a rare occurrence, this report calls attention to a potentially lethal adverse effect of infliximab, underscoring the need to rule out pre-existing liver disease before initiating IFX therapy. Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 11, 2015 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Infliximab Dose Doubling in Patients With Ulcerative ColitisInfliximab Dose Doubling in Patients With Ulcerative Colitis
What does the latest research tell us about the efficacy and safety of infliximab dose doubling in ulcerative colitis patients with a loss of response to infliximab? Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 9, 2015 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Crohn's and Colitis Impact Extends Beyond Patients
Twenty-four-year-old Lauren began experiencing excruciating intestinal pain in June 2012. Two months later, as she was facing the removal of portions of her small and large intestines, Lauren was diagnosed with Crohn's disease. Sitting by her side in the hospital and standing by her in the years that followed her diagnosis were her parents, grandfather, brother, sister, boyfriend, five best friends, gastroenterologist, surgeon, physician's assistant, and nutritionist. These 15 individuals make up Lauren's core support system -- the people who, while they may not have the disease themselves (although some do), are affected ...
Source: Healthy Living - The Huffington Post - November 23, 2015 Category: Consumer Health News Source Type: news

Immune Pharmaceuticals Announces Enrollment Of The First Patient Into The Phase 2 Clinical Trial With Bertilimumab In Ulcerative Colitis
Immune Pharmaceuticals Inc. (NASDAQ: IMNP) ("Immune" or the "Company") announced today that the first patient has been enrolled into the Phase 2 clinical trial evaluating the safety and efficacy of its first in class fully human monoclonal antibody, bertilimumab in Ulcerative Colitis (UC). (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 19, 2015 Category: Pharmaceuticals Source Type: news

How Can I Manage Ulcerative Colitis When I Travel?
Just because you’ve been diagnosed with ulcerative colitis doesn’t mean you have to give away your frequent flier miles. WebMD shares tried-and-true travel tips will have you booking that dream vacation now. (Source: WebMD Health)
Source: WebMD Health - November 18, 2015 Category: Consumer Health News Source Type: news

Immune begins patient enrollment in Phase II trial to treat ulcerative colitis
US-based Immune Pharmaceuticals has begun enrolling patients in a Phase II clinical trial of bertilimumab, a potential treatment for ulcerative colitis (UC). (Source: Drug Development Technology)
Source: Drug Development Technology - November 18, 2015 Category: Pharmaceuticals Source Type: news

PURSUIT study shows patient-reported outcomes in UC patients treated with golimumab
Further data analysis from UC CARES report on quality of life and loss of productivity (Source: Pharmacy Europe)
Source: Pharmacy Europe - November 9, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Clinical trials Practical therapeutics Gastroenterology Research continuous clinical response golimumab inflammatory disease Latest News PGA PURSUIT-Maintenance trial Simponi UC CARES ulcerative colitis Source Type: news

Fecal Calprotectin Identifies Healing in Ulcerative Colitis Fecal Calprotectin Identifies Healing in Ulcerative Colitis
Fecal calprotectin was a marker of mucosal healing in patients with ulcerative colitis, but was too variable to replace endoscopy. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 6, 2015 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Histological Assessment of Disease Activity in UCHistological Assessment of Disease Activity in UC
What is the most effective way to histologically assess disease activity in ulcerative colitis? Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 4, 2015 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Genetic Data Suggest Dividing IBD Into Three FormsGenetic Data Suggest Dividing IBD Into Three Forms
Data from a genetic association study suggest that inflammatory bowel disease (IBD) should be divided into a three-group continuum, rather than the current division between Crohn's disease and ulcerative colitis. Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - November 2, 2015 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Stop Using My Disease to Stop Smoking
As part of its 2015 "Tips From Former Smokers" campaign, the CDC aired an anti-smoking ad that portrayed ostomies as punishment for a bad habit. This turned out to be part of a larger campaign that took advantage of diseases and complications tied to much more than smoking, twisting life-saving and preventative medical care into something akin to torture. Case in point, an ostomy isn't simply what you get for smoking your way to colorectal cancer. Ostomies also save thousands living with severe, incurable Irritable Bowel Disease (IBD). I'm a nonsmoker living with IBD, and I work in advertising. When I saw the CD...
Source: Healthy Living - The Huffington Post - October 27, 2015 Category: Consumer Health News Source Type: news

S1P-R Modulator in Ulcerative Colitis: 'Hotel California' Tx? (CME/CE)
(MedPage Today) -- Ozanimod sequestration: Lymphocytes get in but they cant get out (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - October 21, 2015 Category: Primary Care Source Type: news

Selecting Therapeutic Targets in IBD (STRIDE)Selecting Therapeutic Targets in IBD (STRIDE)
Can these recommendations change disease course and improve quality of life in patients with Crohn's disease or ulcerative colitis? The American Journal of Gastroenterology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 19, 2015 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Site of inflammatory bowel disease crucial
(Wellcome Trust Sanger Institute) A groundbreaking study of more than 30,000 patients with inflammatory bowel disease has shown that genetic factors affect the location of the inflammation in the gut, with important implications for diagnosis and treatment of patients.The largest study of its kind, this research uncovered a genetic similarity between Crohn's disease and ulcerative colitis, suggesting they form a continuum of subtypes in the bowel. That genetic information could be used to inform treatment and reveal misdiagnoses. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - October 19, 2015 Category: Biology Source Type: news

No, Omega 3-Enriched Beef Is Not Necessarily Heart Healthy
Feeding cattle flaxseed or marine algae can raise the omega-3 fatty acid levels in ground beef from 30 milligrams per serving to 200 milligrams per serving, as Kansas State University researchers have found. But do higher levels of omega-3s make red meat significantly healthier?   Not according to Kim Larson, a registered dietitian nutritionist and spokesperson for the Academy of Nutrition and Dietetics. The attempt to make beef look like an important source of omega-3s is essentially a marketing ploy, she said. And despite the fatty acid's reputation as a health ...
Source: Science - The Huffington Post - October 14, 2015 Category: Science Source Type: news

IBD: Postoperative Mortality High After Emergent ResectionIBD: Postoperative Mortality High After Emergent Resection
After emergent intestinal resection, some 3.6% of patients with Crohn disease and 5.3% of patients with ulcerative colitis died; postoperative mortality risk was lower with elective surgery for both. Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - October 9, 2015 Category: Gastroenterology Tags: Gastroenterology News Source Type: news